Tetracyclines improve experimental lymphatic filariasis pathology by disrupting interleukin-4 receptor-mediated lymphangiogenesis.
J Clin Invest. 2021 Mar 1;131(5):e140853. doi: 10.1172/JCI140853.
J Clin Invest. 2021.
PMID: 33434186
Free PMC article.